[Home]
[Full version]
Poor countries to get new AIDS pill
Jul 06 ,Medicine & Health
A new 3-in-1 AIDS pill made in India and approved by U.S. drug regulators is expected to treat patients in poor countries.
The pill made by an Indian generic drug company is the first such antiretroviral treatment approved by the Food and Drug for patients in countries helped by the President's Emergency Plan for AIDS Relief, reports The New York Times.
Dr. Mark R. Dybul, the White House global AIDS coordinator, said the new pill should greatly improve treatment for patients in poor countries.
Under a White House plan, the United States has become the largest provider of antiretroviral drugs in the world. The plan helps treat some 561,000 patients in Africa, Asia and the Caribbean, the Times reported.
The new pill, made by Aurobindo Pharma of Hyderabad, India, combines three common first-line drugs, AZT, 3TC and NVP, which are sold in the United States as Retrovir, Epivir and Viramune, the report said.
Copyright 2006 by United Press International
Related stories:
New study finds HIV drug can persist in mothers' milk, increasing risk to them and their babies
A drug commonly used in the developing world to prevent transmission of HIV from mother to child persists in the breast milk and blood of the mothers, putting them and their babies at risk for developing drug-resistant strains of the virus, according to researchers at the Stanford University School of Medicine.
Scientists test device to track medication adherence in patients with HIV/AIDS
Most of us have missed a dose of antibiotic or forgotten to take a daily vitamin. But when the stakes are higher — as they are for people with HIV/AIDS — a skipped pill could mean the difference between health and hazard for the entire population.
New antibiotic drug combo to speed up treatment of tuberculosis
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.
Mayo study: A simple tool can enhance how patients with diabetes take their medications
Though diabetes contributes to nearly a quarter million deaths in the United States annually, patients with chronic ailments don't always take their medication as prescribed. A Mayo Clinic research team has designed a simple tool to improve compliance with life-saving medications. The tool is clearly effective and preferred by 84 percent of patients, according to a study published in the May 28 issue of the Archives of Internal Medicine.
Research leads to first treatment for drug-resistant HIV
Doctors have their first FDA-approved tool to treat drug-resistant HIV thanks to a new molecule created by a Purdue University researcher.
Pfizer resuming ads for Lipitor after controversy
(AP) -- Television ads for the world's top-selling drug, cholesterol fighter Lipitor, are back, six months after Pfizer Inc. pulled them amid charges its use of a celebrity doctor endorser who's never practiced medicine misled the public. This time, Pfizer is leaving out the celebrity.
Watch out for drug names that look, sound alike
(AP) -- Take the generic drug clonidine for high blood pressure? Double-check that you didn't leave the drugstore with Klonopin for seizures, or the gout medicine colchicine.
New sensory devices will aid Parkinson's and stroke patients
People who have suffered a stroke or who have been diagnosed with Parkinson's disease, could benefit from new research at Queen's University Belfast.
[Home]
[Full version]